Daliap, Mitchelo L.
HRN: 09-38-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2022
CEFUROXIME 1.5GM (VIAL)
08/22/2022
08/28/2022
IV
900mg
Q8Hrs
Tc SVI R/i DF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes